Cognition Therapeutics annual free cash flow
2020
2021
2022
2023
2024
Cognition Therapeutics Free Cash Flow (FCF) History (CGTX)
Cognition Therapeutics reported −$28.5M in free cash flow for fiscal 2024, a decrease of $12.3M from the previous fiscal year.
View full Cognition Therapeutics company overviewCognition Therapeutics free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$28.5M | −$12.3M | — | — |
| 2023 | 2023-12-31 | −$16.2M | $2.5M | — | — |
| 2022 | 2022-12-31 | −$18.7M | −$15.0M | — | — |
| 2021 | 2021-12-31 | −$3.7M | −$215,000 | — | — |
| 2020 | 2020-12-31 | −$3.4M | — | — | — |
Cognition Therapeutics quarterly free cash flow
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | −$6.9M | −$4.1M | — | — |
| Q4 2023 | 2023-12-31 | −$5.5M | $4.7M | — | — |
| Q3 2023 | 2023-09-30 | −$4.2M | −$4.2M | — | — |
| Q2 2023 | 2023-06-30 | −$3.7M | $1.6M | — | — |
| Q1 2023 | 2023-03-31 | −$2.7M | $376,000 | — | — |
| Q4 2022 | 2022-12-31 | −$10.2M | — | — | — |
| Q3 2022 | 2022-09-30 | −$27,000 | — | — | — |
| Q2 2022 | 2022-06-30 | −$5.4M | — | — | — |
| Q1 2022 | 2022-03-31 | −$3.1M | — | — | — |
Cognition Therapeutics free cash flow growth trends
Cognition Therapeutics's latest reported quarter, Q3 2024, generated −$6.9M in free cash flow, a decrease of $4.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Cognition Therapeutics filings at SEC.gov ↗